RESUMEN
INTRODUCTION: For a large-scale trap-neuter-return program 119 cats were anaesthetised with an intramuscular combination of 0,03-0,05 mg/kg medetomidine, 7-10 mg/kg ketamine and 0,4 mg/kg butorphanol. Cats received intraoperative 4 mg/kg tolfenamic acid subcutaneously and before closure of abdominal wall either 2 mg/kg ropivacaine (ROPI) intraperitoneal or saline (NaCl) in equal volumes. Pain was scored one, six and 20 hours postoperative with the modified Glasgow Composite Pain Scale (mGCPS) and the modified Colorado State University Scale (mCSU). There was no significant difference in the pain scores between the two groups, but the pain scores with both pain scales were significant higher (p < 0,001 for both) six hours compared to one and 20 hours postoperative. Cut-off value on the pain scales (necessitating rescue analgesia) was exceeded in 34,5 % for mGCPS and in 39,5 % for mCSU. Cats with a higher pain score showed a lower food intake (p .
INTRODUCTION: L'objectif de cette étude clinique prospective, randomisée, en aveugle et d'observation était d'étudier les effets de la ropivacaïne administrée par voie intrapéritonéale pour l'analgésie postopératoire chez des chats harets femelles subissant une ovariectomie. Dans le cadre d'un programme de piégeage, de stérilisation et de remise en liberté à grande échelle, 119 chattes ont été anesthésiées par une combinaison intramusculaire de 0,03 à 0,05 mg/kg de médétomidine, 7 à 10 mg/kg de kétamine et 0,4 mg/kg de butorphanol. Les chats ont reçu en peropératoire 4 mg/kg d'acide tolfénamique par voie sous-cutanée et, avant la fermeture de la paroi abdominale, 2 mg/kg de ropivacaïne (ROPI) par voie intrapéritonéale ou du sérum physiologique (NaCl) en volumes égaux. La douleur a été évaluée une, six et 20 heures après l'opération à l'aide de l'échelle de Glasgow de la douleur composite modifiée (mGCPS) et de l'échelle modifiée de l'Université d'État du Colorado (mCSU). Il n'y avait pas de différence significative dans les scores de douleur entre les deux groupes, mais les scores de douleur avec les deux échelles de douleur étaient significativement plus élevés (p < 0,001 pour les deux) six heures par rapport à une et 20 heures postopératoires. La valeur seuil des échelles de douleur (nécessitant une analgésie de secours) a été dépassée dans 34,5 % des cas pour le mGCPS et dans 39,5 % des cas pour le mCSU. Les chats ayant un score de douleur plus élevé ont présenté une prise alimentaire plus faible (p < 0,001). L'administration intrapéritonéale de ropivacaïne n'a pas amélioré significativement l'analgésie par rapport à une solution saline intrapéritonéale. La combinaison anesthésique couramment utilisée en pratique pour la stérilisation (médétomidine, kétamine, butorphanol), complétée par des médicaments analgésiques non stéroïdiens supplémentaires, a entraîné une analgésie postopératoire insuffisante 6 heures après la chirurgie chez plus d'un tiers des chats étudiés.
Asunto(s)
Analgesia , Manejo del Dolor , Gatos , Animales , Ropivacaína , Manejo del Dolor/veterinaria , Analgesia/veterinaria , Dolor/veterinaria , ButorfanolRESUMEN
To reduce pain after total hip replacement (THR), researchers are interested in drug-free interventions. However, there is still a lack of consensus on their prevention efficacy. We performed a meta-analysis to evaluate the use of nonpharmaceutical interventions for postoperative pain management after THR. We searched the Cochrane Library, MEDLINE, EMBASE, Web of Science, PEDRO, and ClinicalTrials.gov databases for articles published between and 1991 and 2020. The main outcome measures were postoperative pain, opioid consumption, and quality of life (QoL). In total, 1,942 patients were studied. We found moderate evidence indicating postoperative pain relief measured by the Western Ontario and McMaster Universities Arthritis Index Scale, with mean differences (MDs) of -0.28 (95% confidence interval [CI], -0.49 to -0.07; P=0.01; I2 =0%) within three months, -0.19 (95% CI, -0.40 to 0.02; P=0.07; I2 =0%) between 3-6 months, and -0.13 (95% CI, -0.35 to 0.08; P=0.21; I2 =0%) between 6-12 months. Additionally, we found that acupuncture therapy could reduce opioid analgesic consumption (MD, -0.98; 95% CI, -1.18 to -0.79; fentanyl [mg/h]; P<0.01; I2 =72.2%) and significantly improve pain relief with an MD of 0.90 (95% CI, 0.47 to 1.33; P<0.01; I2 =0%) measured using the visual analog scale. Electrotherapy slightly improved perceived pain with an MD of 0.22 (95% CI, -0.27 to 0.70; P=0.37; I2 =0%). Moreover, moderate evidence has shown that preoperative exercises improve QoL. This meta-analysis suggested that continuous passive motion did not improve pain or QoL. Postoperative exercise was associated with pain relief and improved QoL. Acupuncture therapy after THR has been shown to reduce opioid analgesic consumption.
RESUMEN
INTRODUCTION: The prevalence of knee osteoarthritis is on the raise. This raise has been a huge financial burden to developed countries in treating the disease. Transcutaneous electrical nerve stimulation (TENS) is a cost-effective, easily available, and self-applicable mode of non-pharmacological pain relieve technique. Despite these advantages, the use, settings, and effectiveness of portable TENS are still poorly understood. The aim of this study is to determine the effectiveness of portable TENS at different frequencies in treating knee osteoarthritis. MATERIALS AND METHODS: This is a single-center quasi-experimental study involving 100 patients seen in the outpatient department with knee osteoarthritis. They were randomly (computer generated) allocated into two arms (high frequency [H-F] or low frequency [L-F]). H-F is set at 100 Hz and L-F is set at 4 Hz. A baseline assessment is taken with the visual analog score (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Oxford Knee Score, and Lequesne index. They were instructed to self-administer the TENS therapy as per protocol and followed up at the 4th and 12th week to be reevaluated on the above scores. RESULTS: The final results show that both H-F and L-F groups showed improvement in all parameters of the VAS, WOMAC index, Oxford Knee Score, and Lequesne index (73%). Only the pain component of Lequesne index, activities of daily living component of Lequesne index, total Lequesne index, and pain component of WOMAC index shows a statistically significant difference, favoring the H-F group. The H-F group yields a faster result; however, with time the overall effect remains the same in both groups. CONCLUSION: Both H-F and L-F groups show improvement in all the component of Lequesne index, Oxford Knee Score, WOMAC index, and VAS with no statistical difference between the two groups. Although H-F yields a faster result, not everyone is able to tolerate the intensity. Therefore, the selection of H-F or L-F should be done on case basis depending on the severity of symptoms, patient's expectation, and patient's ability to withstand the treatment therapy. Based on this 12th week follow-up, both groups will continue to improve with time. A longer study should be conducted to see it this improvement will eventually plateau off or continue to improve until the patient is symptom free.